Anadolu Medical Center
The total cost of thymoma treatment in Turkey varies depending on the specific procedures required. An initial consultation costs $140, while a PET-CT scan is $650. Blood tests are priced at $650, hepatitis tests cost $340, and an echocardiogram is $320. A pathology block review, including molecular panel, BRAF mutation, and PDL1 IHK tests, costs $1,440. Chemotherapy courses are priced at $1,590 for the first course and around $1,050 for each subsequent course. The treatment plan is customized based on the patient"s individual condition and needs.
Dr Mustafa Solak specjalizuje się w leczeniu grasiczaka i odbył staż kliniczny w Instytucie Onkologii Uniwersytetu Hacettepe.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.
Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.
Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.
Profesor onkologii klinicznej z bogatym doświadczeniem w zakresie onkologii układu pokarmowego — prof. Sağlam kieruje Oddziałem Onkologii Klinicznej w szpitalu Gayrettepe Florence Nightingale.